201 related articles for article (PubMed ID: 30918199)
41. Inferior survival in high-grade B-cell lymphoma with
McPhail ED; Maurer MJ; Macon WR; Feldman AL; Kurtin PJ; Ketterling RP; Vaidya R; Cerhan JR; Ansell SM; Porrata LF; Nowakowski GS; Witzig TE; Habermann TM
Haematologica; 2018 Nov; 103(11):1899-1907. PubMed ID: 29903764
[TBL] [Abstract][Full Text] [Related]
42. Application of long-distance polymerase chain reaction to detection of junctional sequences created by chromosomal translocation in mature B-cell neoplasms.
Akasaka T; Muramatsu M; Ohno H; Miura I; Tatsumi E; Fukuhara S; Mori T; Okuma M
Blood; 1996 Aug; 88(3):985-94. PubMed ID: 8704258
[TBL] [Abstract][Full Text] [Related]
43. Clinicopathological features of double-hit B-cell lymphomas with MYC and BCL2, BCL6 or CCND1 rearrangements.
Yoshida M; Ichikawa A; Miyoshi H; Kiyasu J; Kimura Y; Arakawa F; Niino D; Ohshima K
Pathol Int; 2015 Oct; 65(10):519-27. PubMed ID: 26224092
[TBL] [Abstract][Full Text] [Related]
44. The Ikaros gene, a central regulator of lymphoid differentiation, fuses to the BCL6 gene as a result of t(3;7)(q27;p12) translocation in a patient with diffuse large B-cell lymphoma.
Hosokawa Y; Maeda Y; Ichinohasama R; Miura I; Taniwaki M; Seto M
Blood; 2000 Apr; 95(8):2719-21. PubMed ID: 10753856
[TBL] [Abstract][Full Text] [Related]
45. Rearrangement of the BCL6 gene in B-cell lymphoid neoplasms: comparison with lymphomas associated with BCL2 rearrangement.
Muramatsu M; Akasaka T; Kadowaki N; Ohno H; Yamabe H; Edamura S; Dor S; Mori T; Okuma M; Fukuhara S
Br J Haematol; 1996 Jun; 93(4):911-20. PubMed ID: 8703825
[TBL] [Abstract][Full Text] [Related]
46. Does the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations?
Mationg-Kalaw E; Tan LH; Tay K; Lim ST; Tang T; Lee YY; Tan SY
Histopathology; 2012 Dec; 61(6):1214-8. PubMed ID: 23171357
[TBL] [Abstract][Full Text] [Related]
47. Molecular cloning of translocation breakpoint from der(8)t(3;8)(q27;q24) defines juxtaposition of downstream of C-MYC and upstream of BCL6.
Sonoki T; Tatetsu H; Nagasaki A; Hata H
Int J Hematol; 2007 Aug; 86(2):196-8. PubMed ID: 17875538
[No Abstract] [Full Text] [Related]
48. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.
Bertrand P; Bastard C; Maingonnat C; Jardin F; Maisonneuve C; Courel MN; Ruminy P; Picquenot JM; Tilly H
Leukemia; 2007 Mar; 21(3):515-23. PubMed ID: 17230227
[TBL] [Abstract][Full Text] [Related]
49. Utility of immunohistochemistry with an antibody against MYC at the initial diagnosis of follicular lymphoma, grade 3A, for predicting a more aggressive clinical course: a case report and review of the literature.
Ichikawa K; Aritaka N; Ogura K; Hosone M; Ota Y; Sato E; Komatsu N; Hirano T
Int J Clin Exp Pathol; 2015; 8(6):7559-64. PubMed ID: 26261669
[TBL] [Abstract][Full Text] [Related]
50. Double-Hit Large B Cell Lymphoma.
Khelfa Y; Lebowicz Y; Jamil MO
Curr Oncol Rep; 2017 Sep; 19(11):74. PubMed ID: 28952038
[TBL] [Abstract][Full Text] [Related]
51. A leukemic double-hit follicular lymphoma associated with a complex variant translocation, t(8;14;18)(q24;q32;q21), involving BCL2, MYC, and IGH.
Minakata D; Sato K; Ikeda T; Toda Y; Ito S; Mashima K; Umino K; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Oh I; Fujiwara SI; Ohmine K; Kawata H; Muroi K; Miura I; Kanda Y
Cancer Genet; 2018 Jan; 220():44-48. PubMed ID: 29310838
[TBL] [Abstract][Full Text] [Related]
52. Diffuse large B-cell lymphoma carrying both t(3 ; 7)(q27 ; p12) and t(8 ; 14)(q24 ; q32).
Katsura Y; Ohta I; Yoshida C; Ohtani H; Komeno T
Intern Med; 2011; 50(8):905-8. PubMed ID: 21498940
[TBL] [Abstract][Full Text] [Related]
53. Case of B-cell lymphoma with rearrangement of the BCL1, BCL2, BCL6, and c-MYC genes.
Kawakami K; Miyanishi S; Sonoki T; Nakamura S; Nomura K; Taniwaki M; Murata T; Kadowaki S; Kadowaki N; Miura I
Int J Hematol; 2004 Jun; 79(5):474-9. PubMed ID: 15239399
[TBL] [Abstract][Full Text] [Related]
54. BCL2 and MYC dual-hit lymphoma/leukemia.
Tomita N
J Clin Exp Hematop; 2011; 51(1):7-12. PubMed ID: 21628855
[TBL] [Abstract][Full Text] [Related]
55. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma.
Chaganti SR; Chen W; Parsa N; Offit K; Louie DC; Dalla-Favera R; Chaganti RS
Genes Chromosomes Cancer; 1998 Dec; 23(4):323-7. PubMed ID: 9824205
[TBL] [Abstract][Full Text] [Related]
56. Concurrent inhibition of MYC and BCL2 is a potentially effective treatment strategy for double hit and triple hit B-cell lymphomas.
Cinar M; Rosenfelt F; Rokhsar S; Lopategui J; Pillai R; Cervania M; Pao A; Cinar B; Alkan S
Leuk Res; 2015 Jul; 39(7):730-8. PubMed ID: 25916698
[TBL] [Abstract][Full Text] [Related]
57. Aggressive B cell Lymphoma: Optimal Therapy for MYC-positive, Double-Hit, and Triple-Hit DLBCL.
Dunleavy K
Curr Treat Options Oncol; 2015 Dec; 16(12):58. PubMed ID: 26634708
[TBL] [Abstract][Full Text] [Related]
58. MYC-associated and double-hit lymphomas: a review of pathobiology, prognosis, and therapeutic approaches.
Petrich AM; Nabhan C; Smith SM
Cancer; 2014 Dec; 120(24):3884-95. PubMed ID: 25060588
[TBL] [Abstract][Full Text] [Related]
59. PLK1: a promising and previously unexplored target in double-hit lymphoma.
Hassan QN; Alinari L; Byrd JC
J Clin Invest; 2018 Dec; 128(12):5206-5208. PubMed ID: 30395539
[TBL] [Abstract][Full Text] [Related]
60. Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma.
Ryan RJ; Drier Y; Whitton H; Cotton MJ; Kaur J; Issner R; Gillespie S; Epstein CB; Nardi V; Sohani AR; Hochberg EP; Bernstein BE
Cancer Discov; 2015 Oct; 5(10):1058-71. PubMed ID: 26229090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
